Our results indicate that imatinib exerts a significant inhibitory effect on breast cancer cell invasion and migration through inhibition of PDGFR and STAT3 phosphorylation, although the expression of PDGF-B was unchanged. This evidence concerns the gene PDGFB and breast cancer.